Search Results - "Vree, Marleen"

Refine Results
  1. 1
  2. 2

    Tissue Distribution and Induction of Human Multidrug Resistant Protein 3 by Scheffer, George L, Kool, Marcel, de Haas, Marcel, de Vree, J Marleen L, Pijnenborg, Adriana C L M, Bosman, Diederik K, Oude Elferink, Ronald P J, van der Valk, Paul, Borst, Piet, Scheper, Rik J

    Published in Laboratory investigation (01-02-2002)
    “…The multidrug resistance protein (MRP) family consists of several members and, for some of these transporter proteins, distinct roles in multidrug resistance…”
    Get full text
    Journal Article
  3. 3

    Delays in the diagnosis and treatment of tuberculosis patients in Vietnam: a cross-sectional study by Huong, Nguyen T, Vree, Marleen, Duong, Bui D, Khanh, Vu T, Loan, Vu T, Co, Nguyen V, Borgdorff, Martien W, Cobelens, Frank G

    Published in BMC public health (13-06-2007)
    “…Treatment delay is an important indicator of access to tuberculosis diagnosis and treatment. Analyses of patient delay (i.e. time interval between onset of…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6
  7. 7

    Mortality and failure among tuberculosis patients who did not complete treatment in Vietnam: a cohort study by Vree, Marleen, Huong, Nguyen T, Duong, Bui D, Sy, Dinh N, Van, Le N, Co, Nguyen V, Cobelens, Frank G J, Borgdorff, Martien W

    Published in BMC public health (02-07-2007)
    “…Tuberculosis treatment failure and death rates are low in the Western Pacific Region, including Vietnam. However, failure or death may also occur among…”
    Get full text
    Journal Article
  8. 8

    High mortality during tuberculosis treatment does not indicate long diagnostic delays in Vietnam: a cohort study by Vree, Marleen, Huong, Nguyen T, Duong, Bui D, Co, Nguyen V, Sy, Dinh N, Cobelens, Frank G, Borgdorff, Martien W

    Published in BMC public health (16-08-2007)
    “…Delay in tuberculosis diagnosis and treatment initiation may increase disease severity and mortality. In evaluations of tuberculosis control programmes high…”
    Get full text
    Journal Article
  9. 9

    Immune responses in DAA treated chronic hepatitis C patients with and without prior RG-101 dosing by van der Ree, Meike H., Stelma, Femke, Willemse, Sophie B., Brown, Anthony, Swadling, Leo, van der Valk, Marc, Sinnige, Marjan J., van Nuenen, Ad C., de Vree, J. Marleen L., Klenerman, Paul, Barnes, Eleanor, Kootstra, Neeltje A., Reesink, Hendrik W.

    Published in Antiviral research (01-10-2017)
    “…With the introduction of DAA's, the majority of treated chronic hepatitis C patients (CHC) achieve a viral cure. The exact mechanisms by which the virus is…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12
  13. 13

    Hepatocyte-specific expression of the human MDR3 P-glycoprotein gene restores the biliary phosphatidylcholine excretion absent in Mdr2 (-/-) mice by SMITH, A. J, DE VREE, J. M. L, OTTENHOFF, R, OUDE ELFERINK, R. P. J, SCHINKEL, A. H, BORST, P

    Published in Hepatology (Baltimore, Md.) (01-08-1998)
    “…Mice homozygous for a disruption in the Mdr2 gene (Mdr2 (-/-) mice) lack the Mdr2 P-glycoprotein (P-gp) in the canalicular membrane of the hepatocyte and are…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Correction of liver disease by hepatocyte transplantation in a mouse model of progressive familial intrahepatic cholestasis by De Vree, J.Marleen L., Ottenhoff, Roel, Bosma, Piter J., Smith, Alexander J., Aten, Jan, Oude Elferink, Ronald P.J.

    Published in Gastroenterology (New York, N.Y. 1943) (01-12-2000)
    “…Background & Aims: Patients with progressive familial intrahepatic cholestasis (PFIC) type 3 have a mutation in the MDR3 gene, encoding the hepatocanalicular…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18
  19. 19

    Percutaneous Treatment of Peripheral Vascular Malformations in Children: Long-Term Clinical Outcome by van der Linden, Edwin, Otoide-Vree, Marleen, Pattynama, Peter M. T.

    “…Purpose This study was designed to assess the rate of complications and clinical failure at 3 and 12 months after percutaneous treatment of vascular…”
    Get full text
    Journal Article
  20. 20

    Survival and relapse rate of tuberculosis patients who successfully completed treatment in Vietnam by VREE, M, HUONG, N. T, DUONG, B. D, SY, D. N, VAN, L. N, HUNG, N. V, CO, N. V, BORGDORFF, M. W, COBELENS, F. G

    “…SETTING: Reported tuberculosis (TB) cure rates are high in Vietnam with the 8-month short-course chemotherapy regimen. However, long-term treatment outcomes…”
    Get full text
    Journal Article